Theratechnologies (TSE:TH – Get Free Report) will be announcing its earnings results before the market opens on Tuesday, September 26th.
Theratechnologies (TSE:TH – Get Free Report) last posted its quarterly earnings results on Wednesday, July 12th. The company reported C($0.14) EPS for the quarter. The firm had revenue of C$23.84 million during the quarter. Theratechnologies had a negative net margin of 45.09% and a negative return on equity of 1,116.86%.
Theratechnologies Trading Up 0.3 %
Theratechnologies stock opened at C$2.91 on Friday. The business has a 50 day moving average price of C$1.94 and a two-hundred day moving average price of C$1.46. The company has a quick ratio of 0.64, a current ratio of 0.72 and a debt-to-equity ratio of 562.07. The stock has a market cap of C$70.42 million, a price-to-earnings ratio of -1.41, a price-to-earnings-growth ratio of -8.50 and a beta of 1.58. Theratechnologies has a 12 month low of C$1.22 and a 12 month high of C$15.00.
Analyst Ratings Changes
Check Out Our Latest Analysis on Theratechnologies
About Theratechnologies
Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, a recombinant humanized monoclonal antibody, which is an injection for the treatment of multidrug resistant HIV-1 infected patients.
Read More
- Five stocks we like better than Theratechnologies
- How Investors Can Find the Best Cheap Dividend Stocks
- 3 Reasons This Sleeping Giant Is About To Wake Up
- How to Invest in Electric Cars
- MarketBeat Week in Review – 9/18 – 9/22
- Do ETFs Pay Dividends? What You Need to Know
- 52-week Low Names To Tip The Upside Scale In Your Favor
Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with MarketBeat.com's FREE daily email newsletter.
